Among these compounds, caffeic acid (compound 5) can be mentioned, which reduced A53T α-synuclein, activating JNK/Bcl-2-mediated autophagy in an in vitro model, and protected dopaminergic neurons in an in vivo model of PD.59 The gene discussed is BCL2; the disease is Parkinson disease.